ELIZABETH WRIGHT: Open Payments
NPI 1811688724 · BELLEFONTE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 54 payments from 9 companies in 2025. Trend: 2023 $111 · 2024 $380 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $425 |
| PFIZER INC. | 9 | $238 |
| Novo Nordisk Inc | 4 | $64 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Lilly USA, LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: NURTEC ODT, QULIPTA, VRAYLAR, UBRELVY, PREVNAR 20, SHINGRIX, MOUNJARO, Ozempic.
Industry payments across PA — which companies pay providers there.
